Affordable Access

deepdyve-link
Publisher Website

Using functional signature ontology (FUSION) to identify mechanisms of action for natural products.

Authors
  • Mb, Potts
  • Hs, Kim
  • Kw, Fisher
  • Y, Hu
  • Yp, Carrasco
  • Gb, Bulut
  • Yh, Ou
  • Ml, Herrera-Herrera
  • F, Cubillos
  • S, Mendiratta
  • G, Xiao
  • M, Hofree
  • Trey Ideker
  • Y, Xie
  • Lj, Huang
  • Re, Lewis
  • Jb, Macmillan
  • Ma, White
Type
Published Article
Journal
Science Signaling
Publisher
American Association for the Advancement of Science (AAAS)
Volume
6
Issue
297
Identifiers
DOI: 10.1126/scisignal.2004657
Source
Ideker Lab
License
Unknown

Abstract

A challenge for biomedical research is the development of pharmaceuticals that appropriately target disease mechanisms. Natural products can be a rich source of bioactive chemicals for medicinal applications but can act through unknown mechanisms and can be difficult to produce or obtain. To address these challenges, we developed a new marine-derived, renewable natural products resource and a method for linking bioactive derivatives of this library to the proteins and biological processes that they target in cells. We used cell-based screening and computational analysis to match gene expression signatures produced by natural products to those produced by small interfering RNA (siRNA) and synthetic microRNA (miRNA) libraries. With this strategy, we matched proteins and miRNAs with diverse biological processes and also identified putative protein targets and mechanisms of action for several previously undescribed marine-derived natural products. We confirmed mechanistic relationships for selected siRNAs, miRNAs, and compounds with functional roles in autophagy, chemotaxis mediated by discoidin domain receptor 2, or activation of the kinase AKT. Thus, this approach may be an effective method for screening new drugs while simultaneously identifying their targets.

Report this publication

Statistics

Seen <100 times